TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
7.07
-0.02 (-0.28%)
Jun 3, 2025, 1:06 PM - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $5.89 million as of June 3, 2025. Its market cap has increased by 10.35% in one year.
Market Cap
5.89M
Enterprise Value
-5.66M
1-Year Change
10.35%
Ranking
Category
Stock Price
$7.07
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $5.89M, a decrease of -87.69%. That is a compound annual growth rate of -41.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 5.91M | 151.90% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |